Cerebrospinal Fluid Amyloid-β (Aβ) as an Effect Biomarker for Brain Aβ Lowering Verified by Quantitative Preclinical AnalysesYasong Lu, Martin Pettersson, Éva Hajós‐Korcsok et al.|Journal of Pharmacology and Experimental Therapeutics|2012Cited by 36